why choose us

First received: August 12, 2024

Clinical Trial: A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Prostatic Neoplasms

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label, Fixed-Sequence Study to Evaluate the Effects of Multiple Doses of Diltiazem on the Single-Dose Pharmacokinetics of MK-5684 in Healthy Adult Male Participants

Brief Summary: Researchers have designed a study medicine called MK-5684 as a new way to treat prostate cancer.The purpose of this study is to learn what happens to MK-5684 in a person's body over time (a pharmacokinetic or PK study).Researchers will compare what happens to MK-5684 in the body when it is given with and without another medicine called diltiazem.

Read more